Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2025-12-25 @ 2:13 AM
NCT ID:
NCT02026960
Eligibility Criteria:
Inclusion Criteria:
A subject with metastatic RCC, who in the opinion of the treating physician, is a potential candidate for inclusion in this study if all of the following criteria apply:
1. 18 years of age or older.
2. Suspected RCC, in the opinion of the investigator
3. Availability of either:
* Nephrectomy or other surgically removed tissue (Stage I); or,
* Metastatic RCC biopsy tissue utilizing needle or core biopsy procedures (Stage II).
4. ≥5 biopsy specimens available from BRPC.
* Subjects who are having a surgical procedure (i.e. metastasectomy, nephrectomy) will have these core biopsies obtained from the surgical specimen, per the BRPC protocol.
5. Not currently being treated with systemic therapy.
Exclusion Criteria:
1. Tumor tissue is committed to other use or inadequate for RNA analysis.
2. Insufficient tissue is collected in the BRPC.
Expansion Cohort for Genitourinary Cancers:
Inclusion Criteria:
1. 18 years of age or older
2. Suspected bladder, prostate, or testicular cancer, in the opinion of the investigator.
3. Availability of surgically removed tissue or biopsy tissue.
4. At least 2 biopsy specimens available from BRPC
5. Not currently being treated with systemic therapy.
Exclusion Criteria:
1. Tumor tissue is committed to other use or inadequate for RNA analysis.
2. Insufficient tissue is collected in the BRPC.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02026960
Study Brief:
Protocol Section:
NCT02026960